Case Study
Clarifying Reimbursement Pathways to Protect Investment
A medical device company partnered with CWH Advisors to evaluate reimbursement pathways, validate its go-to-market strategy, and establish realistic timelines to revenue, helping leadership make informed investment decisions and avoid significant unanticipated costs.
Client Pain Points
- Needed clarity related to time-to-revenue and anticipated reimbursement for a new device in process of FDA approval prior to making material related investments.
- Needed validation of Go-to-Market strategy and the overall economic model for the business initiative.
- Needed market validation with Medicare Advantage payer market on reimbursement and time-to-revenue on product.
CWH Solutions
- Performed a complete Go-to-Market assessment, providing a market-informed plan, execution recommendations, and P&L guidance.
- Provided fee schedules timeline for Centers for Medicare & Medicaid Services and Medicare Advantage payer market.
CWH Delivering Value
- Provided critical direct market feedback from Medicare Advantage payers on their process, timing, and requirements to accommodate new device into fee schedules.
- Saved client a large amount of investment dollars understanding realistic time-to-revenue.
